French health authorities have approved the use of an anti-body treatment made by AstraZeneca for high-risk people who show resistance to vaccines against coronavirus. The independent public health body HAS Friday night announced “a greenlight for the preventive use of Evusheld… for patients with a very high-risk of contracting a severe form of COVID-19”. Evusheld, developed by the British-Swedish pharma […]

This past week, the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) authorized Pfizer COVID-19 booster vaccinations for 16 and 17-year-olds who are six months past their initial vaccination series. Unlike previous changes in COVID-19 vaccination eligibility, boosters for this age group were authorized directly by the FDA and CDC without input from their advisory […]

A study from Memorial Sloan Kettering Cancer Center (MSK) published today in the New England Journal of Medicine (NEJM), found that in patients with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL) Polatuzumab vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) resulted in a 27 percent reduction in risk of disease progression or death compared with the current standard of care […]

Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin ('UCD') and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office. The Company will continue its due diligence on MelioVac, a […]

A team of researchers at Johns Hopkins Bloomberg School of Public Health has created and posted online a free Lyme and tick-borne disease dashboard. The group has published a paper describing the information available on the dashboard and how to use it on the open-access site PLOS ONE. As the researchers note, tick-borne diseases are on the rise in the […]

Many antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections since the inception of the coronavirus disease 2019 (COVID-19) pandemic. This is important because therapeutics reduce hospitalization and effectively neutralize the virus in patients with mild to moderate symptoms. The therapeutics developed thus far mainly target the SARS-CoV-2 spike protein, but their efficiency has been […]

Among the international scientists working to awaken greater attention to sleep in government policymaking circles, LDI Senior Fellow and University of Pennsylvania faculty member Heather Schofield, Ph.D., was featured in the recent special edition of Science magazine focused on sleep research. Co-authoring one of the two lead articles in the influential Science Policy Forum that opened a 37-page special sleep […]

WELLINGTON, New Zealand (AP) — Australia’s Deputy Prime Minister Barnaby Joyce said Thursday he’d tested positive for the coronavirus while traveling in Washington D.C. Joyce, who is fully vaccinated, said in a Facebook post that he’d been experiencing mild symptoms and decided to get tested. He said he would remain in isolation while seeking further advice. He said the remaining […]

(Reuters) – Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible to the rapid changes of the coronavirus, leading virologists and immunologists told Reuters. Most first-generation COVID-19 vaccines target the spike protein on the outer surface of the SARS-CoV-2 virus used to infect human cells. Omicron has prompted alarm among scientists because it has […]

Type 2 diabetes can be a 'devastating diagnosis' says expert We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info Type 2 diabetes means a person’s pancreas cannot produce enough insulin […]